From: The need to reform our assessment of evidence from clinical trials: A commentary
Components |
---|
Study Design: |
   Randomized |
   Allocation concealment |
   Blinding (if possible)* |
   Clinically important and objective primary outcome |
   Beta-error** |
   Multi-centre |
Study Conduct: |
   Intention-to-treat analysis |
   Follow-up or attrition rate |
   Completion to planned numbers |
Study Findings: |
   Biological plausibility |
   Strength of estimate of effect |
   Precision of estimate of effect |
   Observed event rate |
Study Applicability: |
   Complex intervention |
   Consistency across similar studies |
   Generalizability |
   Cost of intervention |